VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
About VCBeat
Why VCBeat
Log In
Home
Alphamab Oncology Surges 8% as Two Studies Selected for ASCO 2026
Alphamab Oncology Surges 8% as Two Studies Selected for ASCO 2026
May 26, 2026 15:33 CST Updated 16:30
Share: